M Pfeffer Selected Research

M Pfeffer Research Topics

Disease

5	Myocardial Infarction 08/2006 - 05/2000
4	Heart Failure 05/2007 - 01/2000
3	Stroke (Strokes) 05/2007 - 06/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 08/2006
2	Neoplasms (Cancer) 05/2014 - 12/2005
2	Infections 01/2014 - 07/2001
2	Inflammation (Inflammations) 08/2006 - 05/2000
2	Atrial Fibrillation 06/2006 - 06/2006
2	Hemorrhage 06/2006 - 10/2004
1	Lipedema 01/2021
1	Fibrosis (Cirrhosis) 10/2017
1	Chronic Renal Insufficiency 01/2016
1	Anemia 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 05/2013
1	Fever (Fevers) 04/2012
1	Coronary Disease (Coronary Heart Disease) 05/2007
1	Isolated Systolic Hypertension 08/2006
1	Hypertension (High Blood Pressure) 08/2006
1	Glioblastoma (Glioblastoma Multiforme) 12/2005
1	Neuroblastoma 12/2005
1	Acute Coronary Syndrome 10/2004
1	Ventricular Remodeling 12/2001
1	Anthrax 07/2001
1	Parasitic Diseases (Parasitic Disease) 01/2001
1	Hypotension (Low Blood Pressure) 06/2000
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2000
1	Ischemia 05/2000
1	Left Ventricular Dysfunction 05/2000
1	Infarction (Infarctions) 05/2000
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2000

Drug/Important Bio-Agent (IBA)

3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2006 - 06/2000
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2000 - 01/2000
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2000 - 01/2000
2	Peptides (Polypeptides)IBA 10/2017 - 12/2001
2	RutheniumIBA 05/2014 - 12/2005
2	Clopidogrel (Plavix)FDA Link 06/2006 - 06/2006
2	Irbesartan FDA LinkGeneric 06/2006 - 06/2006
2	candesartanIBA 06/2003 - 01/2000
1	Procollagen Type IIBA 10/2017
1	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2017
1	Darbepoetin alfa (Aranesp)FDA Link 01/2016
1	NucleotidesIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	AntibodiesIBA 04/2012
1	Pharmaceutical PreparationsIBA 05/2007
1	CholesterolIBA 08/2006
1	Coenzyme A (CoA)IBA 08/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2006
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2006
1	Oxidoreductases (Dehydrogenase)IBA 08/2006
1	AnticoagulantsIBA 06/2006
1	Organometallic CompoundsIBA 12/2005
1	Cytostatic AgentsIBA 12/2005
1	Cisplatin (Platino)FDA LinkGeneric 12/2005
1	Tirofiban (Aggrastat)FDA Link 10/2004
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2004
1	Heparin (Liquaemin)FDA LinkGeneric 10/2004
1	Natriuretic AgentsIBA 12/2001
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2001
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2001
1	N-terminal proatrial natriuretic peptideIBA 12/2001
1	EnzymesIBA 07/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2000
1	candesartan cilexetil (Amias)FDA Link 01/2000
1	Angiotensin IIIBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2016 - 05/2000
1	Ketogenic Diet 01/2021
1	Contraindications 06/2006
1	Intraperitoneal Injections 01/2001